PETMED EXPRESS INC (PETS) Financial Statements — Income, Balance Sheet, Cash Flow

Overview Financials Chart Business Summary Filings Ownership Valuation

Financial Statements — PETS

Balance Sheet

(in millions USD)

Metric	Q1 2027	Q3 2026	Q2 2026	Q1 2026	Q3 2025	Q2 2025	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q2 2022	Q1 2022	Q3 2021	Q2 2021	Q1 2021
Cash & Equivalents	13.08	26.91	36.10	41.13	50.10	52.05	45.99	49.44	53.47	61.53	102.43	96.55	105.41	106.56	111.79	108.91	106.34	86.82
Accounts Receivable	1.71	1.56	1.97	1.61	2.26	1.62	2.26	1.93	2.17	1.89	1.94	1.59	1.78	1.85	2.16	1.27	2.21	2.71
Inventory	8.47	12.21	14.77	18.36	11.80	13.09	--	--	--	--	--	--	--	--	--	--	--	--
Total Current Assets	27.61	48.51	59.46	67.89	68.38	70.78	77.62	95.55	84.64	104.81	134.02	138.22	134.19	133.45	147.18	142.90	132.62	135.88
Property, Plant & Equipment	25.21	27.55	28.34	28.84	28.43	26.20	26.11	26.81	26.97	27.21	25.24	25.19	24.69	25.08	25.28	24.67	25.47	26.02
Goodwill	--	0.00	0.00	0.00	26.66	26.66	26.66	26.66	26.66	26.66	--	--	--	--	--	--	--	--
Intangible Assets	5.25	5.98	6.47	6.96	9.74	10.22	10.71	11.69	12.18	12.67	--	--	0.86	0.86	0.86	0.86	0.86	0.86
Total Non-current Assets	36.16	39.46	40.85	41.95	76.41	75.26	75.09	77.80	78.06	79.47	31.10	31.05	30.55	25.94	26.14	25.53	26.33	26.88
Total Assets	63.76	87.97	100.30	109.84	144.79	146.03	152.71	173.35	162.70	184.28	165.12	169.27	164.74	159.39	173.32	168.43	158.95	162.76
Accounts Payable	12.30	20.30	19.12	20.04	10.95	16.95	24.47	38.85	25.38	40.04	24.32	23.98	17.03	11.18	24.71	21.94	16.06	20.98
Total Current Liabilities	40.60	54.77	56.68	57.62	47.96	48.83	58.30	72.40	61.24	78.76	31.07	30.57	23.90	16.27	31.86	26.27	21.16	29.17
Total Non-current Liabilities*	0.18	0.43	0.55	0.68	0.65	0.77	0.88	0.89	1.08	1.27	0.47	0.55	0.64	1.63	1.11	1.26	1.38	0.72
Total Liabilities	40.77	55.20	57.24	58.29	48.61	49.60	59.18	73.29	62.32	80.03	31.54	31.11	24.54	17.90	32.98	27.53	22.54	29.88
Retained Earnings	3.12	13.32	23.87	32.39	78.19	78.89	76.56	76.56	78.58	84.18	116.91	123.25	126.97	132.75	132.49	130.72	131.06	128.30
Total Stockholder Equity	22.99	32.77	43.06	51.55	96.18	96.43	93.53	100.06	100.38	104.24	133.59	138.15	140.20	141.49	140.35	140.90	136.41	132.87

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)

Metric	Q1 2027	Q4 2026	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q2 2022	Q1 2022
Total Revenue	41.02	42.82	40.66	44.36	51.18	46.47	52.98	59.57	67.95	66.50	65.32	71.00	78.24	62.13	58.87	65.39	70.19	66.00	67.39	79.31
Cost of Revenue*	29.68	28.88	31.20	31.95	36.78	27.52	38.08	42.26	49.98	48.33	47.43	50.94	55.72	45.03	43.63	46.94	50.24	46.61	48.21	57.53
Gross Profit	11.33	13.94	9.46	12.42	14.40	18.95	14.91	17.31	17.97	18.18	17.88	20.06	22.53	17.10	15.24	18.45	19.94	19.40	19.17	21.78
Selling, General & Admin	11.20	11.42	12.19	14.18	12.95	12.49	10.79	10.49	4.87	14.15	13.43	11.96	15.71	11.19	10.43	10.75	9.35	8.29	6.96	8.04
Total Operating Expenses	17.57	19.63	19.93	20.80	48.54	24.97	15.36	16.76	13.59	22.01	20.96	19.19	24.65	16.73	16.01	15.49	16.45	12.34	11.09	16.36
Operating Income	(6.23)	(5.69)	(10.47)	(8.38)	(34.13)	(6.02)	(0.45)	0.55	4.39	(3.83)	(3.07)	0.88	(2.13)	0.37	(0.77)	2.96	3.49	7.06	8.09	5.42
Pretax Income	(6.13)	(4.16)	(10.54)	(8.51)	(34.14)	(5.98)	(0.24)	0.93	4.71	(3.48)	(2.64)	1.28	(1.43)	(0.17)	0.20	3.61	3.81	7.43	8.33	5.79
Tax Provision	0.01	(0.10)	0.01	0.01	0.01	5.66	0.47	(1.40)	0.96	1.54	(0.62)	0.56	(0.29)	0.03	0.22	1.03	1.03	1.37	1.98	1.36
Net Income	(6.14)	(4.06)	(10.55)	(8.52)	(34.15)	(11.64)	(0.71)	2.33	3.75	(5.02)	(2.03)	0.72	(1.14)	(0.19)	(0.02)	2.58	2.78	6.07	6.35	4.43
Basic EPS	(0.28)	(0.18)	(0.50)	(0.41)	(1.65)	(0.56)	(0.03)	0.11	0.18	(0.23)	(0.10)	0.04	(0.06)	(0.26)	0.00	0.13	0.14	0.31	0.31	0.22
Diluted EPS	(0.28)	(0.18)	(0.50)	(0.41)	(1.65)	(0.56)	(0.03)	0.11	0.18	(0.23)	(0.10)	0.03	(0.06)	(0.26)	0.00	0.13	0.14	0.30	0.31	0.22

* Derived from reported values

Cash Flow Statement

(in millions USD)

Metric	Q1 2027	Q4 2026	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q2 2022	Q1 2022	Q4 2021
Operating Cash Flow	(7.69)	(4.74)	(9.20)	(2.17)	(12.27)	7.01	(1.17)	7.39	(8.52)	7.13	(2.59)	(0.78)	0.56	9.72	12.97	(1.27)	6.38	1.50	(0.42)	18.45
Capital Expenditures	0.64	0.72	(0.02)	2.62	1.29	2.39	0.78	1.26	0.68	1.25	1.12	0.98	1.15	1.93	0.99	1.35	0.98	0.50	0.48	0.58
Free Cash Flow*	(8.33)	(5.46)	(9.18)	(4.80)	(13.56)	4.62	(1.94)	6.12	(9.20)	5.87	(3.72)	(1.76)	(0.59)	7.79	11.98	(2.63)	5.40	1.00	(0.90)	17.86
Investing Cash Flow	(0.64)	(0.72)	0.02	(2.62)	(1.29)	(2.39)	(0.78)	(1.26)	(0.68)	(1.25)	(1.42)	(0.98)	(37.01)	(1.93)	(0.99)	(1.35)	(5.98)	(0.49)	(0.48)	(0.58)
Financing Cash Flow	-0.00	(0.04)	0.00	(0.23)	(0.03)	-0.00	-0.00	(0.07)	(0.10)	(0.02)	(0.01)	(6.30)	(6.10)	(6.13)	(6.10)	(6.24)	(6.06)	(6.23)	(6.03)	(5.65)

* Derived from reported values

Dividends Per Share

(USD)

Metric	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020
Dividends Per Share	0.00	0.00	0.00	0.00	0.00	0.00	0.30	0.30	0.30	0.30	0.30	0.30	0.30	0.30	0.30	0.28	0.28	0.28	0.28	0.27